Navigation Links
Lilly Reports Second-Quarter 2013 Results
Date:7/24/2013

INDIANAPOLIS, July 24, 2013 /PRNewswire/ --

  • Worldwide revenue increased 6 percent as growth in key products offset lower Zyprexa revenue following patent expirations in most major markets.
  • Cymbalta sales increased 22 percent while Cialis increased 13 percent.
  • Higher revenue and ongoing cost containment drove strong earnings growth.
  • Second quarter earnings per share grew to $1.11 (reported), or $1.16 (non-GAAP).
  • 2013 earnings per share guidance range raised to $4.28 - $4.38 (reported), or $4.05 - $4.15 (non-GAAP)
  • Eli Lilly and Company (NYSE: LLY) today announced financial results for the second quarter of 2013.

     $ in millions, except per share data

    Second Quarter

    %20132012

    GrowthTotal Revenue – Reported

    $5,929.7$5,600.7

    6%Net Income – Reported

    1,206.2923.6

    31%EPS – Reported

     

    1.110.83

    34%Net Income – non-GAAP

    1,254.9923.6

    36%EPS – non-GAAP

    1.160.83

    40% 

    Certain financial information for 2013 and 2012 are presented on both a reported and a non-GAAP basis. Some numbers in this press release may not add due to rounding. Reported results were prepared in accordance with generally accepted accounting principles (GAAP) and include all revenue and expenses recognized during the period. Non-GAAP measures exclude the items described in the reconciliation tables later in the release. The non-GAAP measures are presented in order to provide additional insights into the underlying trends in the company's business. The company's 2013 financial guidance is also being provided on both a reported and a non-GAAP basis.

    "In the second quarter, Lilly delivered solid financial results, highlighted by good revenue growth
    '/>"/>

    SOURCE Eli Lilly and Company
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine technology :

    1. After Reviewing Brief Product Profiles, Surveyed Physicians Believe that Likely Candidates for Late-Phase Chronic Kidney Disease Products from AbbVie, Mitsubishi Tanabe, Eli Lilly, Concert, Fibrogen and Pfizer are Typically Stage 3b and 4 Patients
    2. Lilly Disappointed in Draft Medicare Coverage Decision for Beta-Amyloid Imaging Agents
    3. The Zacks Analyst Blog Highlights: Walgreens, Express Scripts Holding, Haemonetics, ResMed and Eli Lilly
    4. Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests
    5. Lilly Declares Third-Quarter 2013 Dividend
    6. Lilly Voluntarily Terminates Phase II Study for LY2886721, a Beta Secretase Inhibitor, Being Investigated as a Treatment for Alzheimers Disease
    7. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company Statement on the ADA Request for Independent Review of Incretin-Based Therapies
    8. Lilly Statement on Indiana Biosciences Research Institute
    9. Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma
    10. Lilly Announces CEO Dr. John Lechleiter to Undergo Scheduled Surgery
    11. Lilly Declares Second-Quarter 2013 Dividend
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Mallinckrodt plc (NYSE: ... of Directors has approved a share repurchase program. The ... $300 million of Mallinckrodt plc ordinary shares. ... opportunities remain top priorities as we continue to pursue ...
    (Date:1/23/2015)... CHENGDU, China , Jan. 23, 2015 Tianyin ... pharmaceutical company that specializes in the development and sale ... branded generics and active pharmaceutical ingredients (API) today announced ... Facility (JCM) API operation. 1. Following the ...
    (Date:1/22/2015)... MINNEAPOLIS, Jan. 22, 2015  Uroplasty, Inc. (NASDAQ: UPI ... markets innovative proprietary products to treat voiding dysfunctions, today ... ended December 31, 2014.  Global revenue for the ... $4.4 million, a new quarterly revenue record, as compared ...
    Breaking Medicine Technology:Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18
    ... SAN CLEMENTE, Calif., Jan. 23 Today the FDA ... Embryonic Stem Cells,but Adult Stem Cell scientist Christian Drapeau ... Adult Stem Cells have greater potential with less,risk. , ... an exciting step forward toward freeing science,from the shackles ...
    ... Rats Highlighted -PLYMOUTH MEETING, Pa., Jan. 22 /PRNewswire-FirstCall/ ... GENR ) today announced a poster presentation of ... candidate for the treatment of type 2 diabetes ... Novel Aspects of the Regulation of Body Weight ...
    Cached Medicine Technology:FDA Stem Cell Approval Breakthrough Laudable 2Genaera Presents Promising Preclinical Data for Trodusquemine (MSI-1436) at Keystone Symposia 2Genaera Presents Promising Preclinical Data for Trodusquemine (MSI-1436) at Keystone Symposia 3
    (Date:1/22/2015)... January 22, 2015 A new white ... experience and person-centeredness in the long-term care environment as ... across the continuum. The paper, “The Power of Person-Centeredness ... perspectives and practices of the patient, resident and family ...
    (Date:1/22/2015)... has released a new blog post presenting the basic features ... Purchasing an accidental death and dismemberment rider for a car ... provides benefits if the insured dies in an accident. Accidental ... life insurance. , AD&D is not expensive and can ...
    (Date:1/22/2015)... Recently, Weddingshe.com has added many trendy ... its highest annual revenues in the past three years. Today, ... wedding dresses. , According to the sales manager of the ... for them in 2015. This point can be reflected on ...
    (Date:1/22/2015)... EBSCO Information Services (EBSCO) and the American ... effort to further promote visibility and adoption of the top ... AMA journals available via its subscription services, EBSCO will now ... , Long known as both a subscription agency and ...
    (Date:1/22/2015)... January 22, 2015 Lower-Auto-Insurance.com has released a new ... in a car for reducing the costs of an auto ... also be able to get lower prices for their vehicle insurance ... important role in determining policy costs. Because of this, drivers ...
    Breaking Medicine News(10 mins):Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2
    ... Stater Bros. has raised over $6.1 Million for MDA, ... Markets,is pleased to announce that a check for $1,143,000 ... Telethon over the recent Labor Day weekend.,Stater Bros. has ... years., (Logo: http://www.newscom.com/cgi-bin/prnh/20030421/STATERLOGO ), Funds from ...
    ... recalled due to unlisted nut allergen, LANDOVER, Md., ... of Grandma Taylor,s Gourmet Dipping Cookies sold in,Giant,s Bakeshop ... not,declared on the labels. These products were manufactured on ... removed from store,shelves., The following products are affected ...
    ... $1.2 Million Annually to Aid in the Fight Against,Kidney ... today by the National Kidney Foundation of the National ... area,s business, government,health, and community leaders., WHAT: The ... will also enjoy cocktails, dinner, silent and live,auctions, and ...
    ... & Science University Cancer Institute researchers have found the ... cancer tumors in mice, which they hope will translate ... The study was presented today at the 50th annual ... Boston. , Principal investigator Marka Crittenden, M.D., Ph.D., and ...
    ... Women,s muscles may require longer, more intensive rehabilitation ... today by the Institute for Neuromusculoskeletal Research at ... , According to Brian C. Clark, Ph.D., assistant ... to how sex-specific hormones regulate the growth of ...
    ... virus to deliver pluripotent cells circumvents safety concerns, scientists ... report that they have sidestepped a major technical hurdle ... cells. , A team of Boston scientists developed a ... which are functionally similar to embryonic stem cells, but ...
    Cached Medicine News:Health News:Stater Bros. Markets Presents $1,143,000 Check to Muscular Dystrophy Association 2Health News:Women recover muscle strength more slowly than men 2Health News:Researchers Report Stem Cell Advance 2Health News:Researchers Report Stem Cell Advance 3Health News:Researchers Report Stem Cell Advance 4
    ... EMR,systems require you to,change the ... only,electronic patient charting,solution designed to ... around,five specific criteria to,enhance overall ... you to see,more patients in ...
    The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
    Shandon Paraffin Block Cartons...
    The Flash MiniLabeler products can be configured to label microplates, tubes, vials, glass slides, circuit boards and a wide array of small products. Systems perform wrap around (tube or package) lab...
    Medicine Products: